Latest Distributions News

Transurban Group is streamlining operations with a workforce reduction of around 300 roles, targeting over $50 million in annual cost savings while maintaining its FY25 distribution guidance.

Growthpoint Properties Australia has raised its FY25 funds from operations guidance and expanded its logistics portfolio with a $40 million industrial asset acquisition in Queensland, signaling strong operational momentum.

Transurban Group is streamlining operations with a workforce reduction of approximately 300 employees, aiming to save over $50 million annually while maintaining its FY25 distribution guidance.

Super Retail Group has amended its FY25 sales growth figures while reporting improved like-for-like sales in the second half, alongside strategic investments in supply chain and store network expansion.

Super Retail Group updates key sales growth figures while outlining increased costs from system upgrades and distribution centre transitions, signaling a cautious outlook amid mixed retail conditions.

Super Retail Group reports a 3.1% like-for-like sales growth in H2 FY25, driven by key brands and strategic investments in its omni-retail network and supply chain.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

Southern Cross Gold Consolidated has successfully closed the first tranche of a private placement, raising C$88.8 million to advance its Sunday Creek Gold-Antimony Project in Victoria, Australia. The funds will support drilling, resource definition, and early development milestones.

Global Data Centre Group updates its distribution guidance following the AirTrunk divestment, factoring in operational costs and risk reserves that temper immediate payouts.

Prospech Limited reports promising metallurgical test results from its Korsnäs Rare Earth Element resource, highlighting apatite as the dominant and well-liberated mineral. The company is fast-tracking bench-scale concentrate production and hydrometallurgical extraction to advance resource development.

Scentre Group reports rising customer visits and record business partner sales, while advancing major Westfield redevelopments and reaffirming 2025 earnings guidance.

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.